Events & Compliance Reporting Specialist jobs in United States
cer-icon
Apply on Employer Site
company-logo

Establishment Labs · 2 weeks ago

Events & Compliance Reporting Specialist

Establishment Labs is changing the medical device, breast health, aesthetics and reconstruction industry by designing, developing, and manufacturing innovative medical aesthetic device technologies. The Events & Compliance Reporting Specialist ensures accurate management of healthcare professional spend and compliance tracking, supporting cross-functional teams with data accuracy and regulatory adherence.

BiotechnologyHealth CareManufacturingMedical Device

Responsibilities

Collect, review, and validate data related to HCP payments and transfers of value in alignment with Sunshine Act and global transparency requirements
Review, reconcile, and process event-related expenses, ensuring adherence to company policies and local/global compliance guidelines
Manage event data entry in company CRM, event management, or compliance tracking systems
Oversee data collection for HCP travel arrangements, including flights, hotels, and ground transportation, ensuring fair market value and policy compliance

Qualification

Compliance reportingEvent managementData validationMicrosoft Office SuiteCRM systemsBachelor’s degreeTraining in complianceFinance experienceTransparency reporting

Required

Bachelor's degree in Business Administration, Finance, Compliance, or related field
Training in compliance, transparency reporting, or event management
Proficiency in Microsoft Office Suite; familiarity with CRM and compliance reporting systems (e.g., MedCompli, Concur, MedPro, Salesforce)
2+ years of experience in compliance, finance, event management or transparency reporting
Occasional travel (up to 15%) for events or audits

Company

Establishment Labs

twittertwitter
company-logo
Establishment Labs, the next generation breast aesthetics company,

Funding

Current Stage
Public Company
Total Funding
$580.7M
Key Investors
Oaktree Capital ManagementMadryn Asset Management
2024-11-07Post Ipo Equity· $50M
2024-01-09Post Ipo Equity· $50M
2023-04-24Post Ipo Equity· $78.7M

Leadership Team

R
Raj Denhoy
Chief Financial Officer
linkedin
leader-logo
Rosalyn D'incelli
Vice President, Clinical and Medical Affairs
linkedin
Company data provided by crunchbase